Literature DB >> 17855639

Thiazide diuretics exacerbate fructose-induced metabolic syndrome.

Sirirat Reungjui1, Carlos A Roncal, Wei Mu, Titte R Srinivas, Dhavee Sirivongs, Richard J Johnson, Takahiko Nakagawa.   

Abstract

Fructose is a commonly used sweetener associated with diets that increase the prevalence of metabolic syndrome. Thiazide diuretics are frequently used in these patients for treatment of hypertension, but they also exacerbate metabolic syndrome. Rats on high-fructose diets that are given thiazides exhibit potassium depletion and hyperuricemia. Potassium supplementation improves their insulin resistance and hypertension, whereas allopurinol reduces serum levels of uric acid and ameliorates hypertension, hypertriglyceridemia, hyperglycemia, and insulin resistance. Both potassium supplementation and treatment with allopurinol also increase urinary nitric oxide excretion. We suggest that potassium depletion and hyperuricemia in rats exacerbates endothelial dysfunction and lowers the bioavailability of nitric oxide, which blocks insulin activity and causes insulin resistance during thiazide usage. Addition of potassium supplements and allopurinol with thiazides might be helpful in the management of metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855639     DOI: 10.1681/ASN.2007040416

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  48 in total

Review 1.  Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics.

Authors:  Julio D Duarte; Rhonda M Cooper-DeHoff
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-06

2.  Hypertension: Is there a dark side to thiazide therapy for hypertension?

Authors:  Takahiko Nakagawa; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2010-10       Impact factor: 28.314

Review 3.  Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia.

Authors:  Sirirat Reungjui; Thongchai Pratipanawatr; Richard J Johnson; Takahiko Nakagawa
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-09       Impact factor: 2.894

Review 4.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Authors:  Thomas Jensen; Manal F Abdelmalek; Shelby Sullivan; Kristen J Nadeau; Melanie Green; Carlos Roncal; Takahiko Nakagawa; Masanari Kuwabara; Yuka Sato; Duk-Hee Kang; Dean R Tolan; Laura G Sanchez-Lozada; Hugo R Rosen; Miguel A Lanaspa; Anna Mae Diehl; Richard J Johnson
Journal:  J Hepatol       Date:  2018-02-02       Impact factor: 25.083

Review 5.  Thiazide effects and adverse effects: insights from molecular genetics.

Authors:  David H Ellison; Johannes Loffing
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

6.  Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection?

Authors:  Richard J Johnson; Chris Rivard; Miguel A Lanaspa; Silvia Otabachian-Smith; Takuji Ishimoto; Christina Cicerchi; Peter R Cheeke; Bridgett Macintosh; Tanja Hess
Journal:  J Equine Vet Sci       Date:  2013-02       Impact factor: 1.583

Review 7.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

8.  Changes in serum potassium mediate thiazide-induced diabetes.

Authors:  Tariq Shafi; Lawrence J Appel; Edgar R Miller; Michael J Klag; Rulan S Parekh
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

9.  Dietary fructose causes tubulointerstitial injury in the normal rat kidney.

Authors:  Takahiro Nakayama; Tomoki Kosugi; Michael Gersch; Thomas Connor; Laura Gabriela Sanchez-Lozada; Miguel A Lanaspa; Carlos Roncal; Santos E Perez-Pozo; Richard J Johnson; Takahiko Nakagawa
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-13

10.  Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice.

Authors:  Xizhen Xu; Chun Xia Zhao; Luyun Wang; Ling Tu; Xiaosai Fang; Changlong Zheng; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.